Neurocrine Biosciences
NBIX
NBIX
394 hedge funds and large institutions have $8.65B invested in Neurocrine Biosciences in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 138 increasing their positions, 156 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 407 → 394 (-13)
12% less repeat investments, than reductions
Existing positions increased: 138 | Existing positions reduced: 156
20% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 44
Holders
394
Holding in Top 10
5
Calls
$89.4M
Puts
$36.3M
Top Buyers
| 1 | +$117M | |
| 2 | +$61.7M | |
| 3 | +$39.4M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$36.4M |
| 5 |
Millennium Management
New York
|
+$34.9M |
Top Sellers
| 1 | -$72.4M | |
| 2 | -$72.1M | |
| 3 | -$63.2M | |
| 4 |
Rockefeller Capital Management
New York
|
-$56.6M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$54M |